cardiac allograft vasculopathy

Unprotected Left Main Coronary Artery Percutaneous Coronary Intervention in a Pediatric Patient With Cardiac Allograft Vasculopathy

10/27/2014

Michael S. Lee , MD, DPM, FACFAS, FACC, FSCAI;

Sata Kumiko , MD;

Cardiac allograft vasculopathy (CAV) is an immunologically-mediated phenomenon that occurs in up to 50% of patients surviving to 10 years post orthotopic heart transplant. While the pediatric subgroup of OHT recipients has a lower overall...

Cardiac allograft vasculopathy...

10/27/2014

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

March 23 ⁠–⁠ March 24

April 27 ⁠–⁠ April 28

Great Debates & Updates in Diabetic Foot

November 30 ⁠–⁠ December 2

November 27 ⁠–⁠ November 29

December 12 ⁠–⁠ December 13

May 13 ⁠–⁠ May 14

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

cardiac allograft vasculopathy

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products